RGCRegencell Bioscience Holdings Limited

$6.81

Price

$6.81-49%1Y
1M+25%1Y-49%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Lagging
1/10
Value41
Quality3
Momentum29
Growth-
Strongest Value, weakest Quality · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

According to the Centers for Disease Control and Prevention (“CDC”), ADHD is one of the most common neurodevelopmental disorders of childhood. It is usually first diagnosed in childhood and often lasts into adulthood. Children with ADHD may have trouble paying attention, controlling impulsive behaviors, or being overly active. Normal symptoms of ADHD include: having short attention span, easily distracted, constantly fidgeting, excessive physical movement and little or no sense of danger.

In the company’s own words · 20-F filed Oct 31, 2025 · SEC EDGAR

P/E (TTM)-
Market Cap$3.70B
1Y Return-49%
5Y Return+2835%

Raw charts

5 series · TTM

As reported to the SEC, without any scoring.